Florian brings to Cellestia a unique blend of drug development expertise and experience from clinical practice. Prior to joining Cellestia, he was Head of Clinical Development Europe at Rainier Therapeutics. Previously he held roles of increasing responsibility at Novartis Oncology and Amgen in Europe and the US. Before transitioning to the biopharmaceutical industry, Florian had a career as a physician scientist where he practiced medicine and led research projects. Florian received his MD and a PhD in clinical pharmacology from the University of Munich; he completed a postdoctoral fellowship at the International Agency for Research on Cancer in Lyon.
“I am passionate about developing treatments that make a difference in the lives of patients and their families. Cellestia’s innovative science forms the basis for the treatment of patients with cancer who have no other therapeutic options.”